Archive

Private Labels Force a Reckoning on Health and Beauty Shelves

Discover the shift in consumer behavior as private labels gain market share in health and beauty, challenging traditional brands.

World Mental Health Day Highlights Urgent Needs

World Mental Health Day sheds light on Africa’s mental health crisis. Learn about the challenges and necessary actions needed.

RAF Insolvent with R27.8 Billion Deficit Woes

With the RAF insolvent, issues including severe governance failures and a staggering R27.8 billion deficit have been exposed.

Healthcare Facilities Cheat Compliance Checks

Uncover the truth behind facilities that cheat compliance checks by borrowing equipment to pass NHI inspections fraudulently.

Healthcare Access: SAHRC Takes Legal Action Now

The South African Human Rights Commission takes action to secure healthcare access for foreign nationals. Read about the latest developments.

Stark Warning Against NHI: Lessons from Gauteng

Gauteng’s Department of Health provides a stark warning against NHI, highlighting its history of failures and accountability issues.

Low-Cost Benefit Options Fight Reaches Supreme Court of Appeal

The Supreme Court is set to address low-cost benefit options in medical schemes, impacting healthcare access for low-income South Africans.

Poor Sleep Mortality Risk Linked to Irregular Patterns

Explore the link between irregular sleep and increased mortality risk. Poor sleep can lead to serious health consequences.

NHLS Cyberattack: A Decade’s Worst Audit Results

Uncover the effects of the NHLS cyberattack on public health and its alarming audit outcome, revealing millions in debt and instability.

Nobel Prize Highlights Advances in Cancer Immunotherapy

American scientists Mary Brunkow and Fred Ramsdell, alongside their Japanese colleague Shimon Sakaguchi, have been awarded the 2025 Nobel Prize in Physiology or Medicine.

Limpopo Health Budget Under Siege by Legal Claims

The Limpopo health budget faces a severe challenge as half is consumed by medico-legal claims, threatening public health.

FDA Generic Drug Review Boosts US Drug Manufacturing

The US Food and Drug Administration (FDA) has announced the launch of a new pilot programme. This programme aims to accelerate the review process for generic drugs. Companies research, develop, and manufacture these drugs entirely within the United States.